Mutagenesis, Vol. 16, No. 1, 51-58,
January 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press
Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes
Vrije Universiteit Brussel, Laboratorium voor Cellulaire Genetica, Pleinlaan 2, 1050 Brussels, Belgium and 1 CSIRO Health Sciences and Nutrition, PO Box 10041, Gouger Street, Adelaide, SA 5000, Australia
Human biomonitoring of early genetic effects requires accurate, sensitive and, if possible, easy and not too time-consuming methodologies to assess mutations. One of the most promising methodologies at the present time is the cytokinesis block micronucleus (MN) assay (CBMN), which detects both chromosome breakage and chromosome loss in once-divided binucleated (BN) cells. Many studies have been published with this methodology, but before its extensive application is recommended, it is necessary to evaluate its strengths and limitations. Recently, Fenech et al. reviewed the advantages of the CBMN assay for biomonitoring purposes. However, up to now information present in mononucleated (MONO) cells has rarely been taken into account, although it might be complementary to that assessed in BN cells. Indeed, MONO cells should indicate damage which was present in vivo before the start of culture and BN cells may contain pre-existing micronuclei (MNi) plus lesions which are expressed as MNi during in vitro culture. To address this question, the objectives of this paper were as follows. (i) To situate the CBMN assay in a historical and mechanistic perspective. (ii) To consider whether impaired mitotic capacity in vitro may be responsible for false negative biomonitoring studies if MN in MONO cells are not taken into account in the CBMN test. The following factors were considered: division delay for repair and mitotic block, in vitro apoptosis and necrosis of damaged cells, mitotic slippage and correlation between MN expression in vitro versus in vivo. (iii) To analyse the factors which may cause a negative result in the CBMN assay in biomonitoring when exposure to specific genotoxins is evident. The specific effects of aneugens and of adaptive responses to chronic low level exposure were examined. (iv) To compare the sensitivity of MONO and BN cells in relation to the genotoxic mechanism. (v) To propose an adequate sampling scheme to study MN in both MONO and BN cells. It was concluded that a more comprehensive assessment of DNA damage may be achieved if the CBMN assay includes measures of: (i) MNi in MONO cells; (ii) MNi in BN cells; (iii) apoptotic cells; (iv) necrotic cells. It is probable that the 24 h post-phytohaemagglutinin time point may be the optimal time to assess the frequency of MNi in MONO cells, apoptotic cells and necrotic cells. It is also practical to include these measures when scoring MNi in BN cells after cytokinesis block.
2 To whom correspondence should be adressed. Email: mkirschv{at}vub.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. S. Arsoy, S. Neuss, S. Wessendorf, M. Bommer, A. Viardot, P. Schutz, and G. Speit Micronuclei in peripheral blood from patients after cytostatic therapy mainly arise ex vivo from persistent damage Mutagenesis, July 1, 2009; 24(4): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Decordier, A. Papine, G. Plas, S. Roesems, K. Vande Loock, J. Moreno-Palomo, E. Cemeli, D. Anderson, A. Fucic, R. Marcos, et al. Automated image analysis of cytokinesis-blocked micronuclei: an adapted protocol and a validated scoring procedure for biomonitoring Mutagenesis, January 1, 2009; 24(1): 85 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Battershill, K. Burnett, and S. Bull Factors affecting the incidence of genotoxicity biomarkers in peripheral blood lymphocytes: impact on design of biomonitoring studies Mutagenesis, November 1, 2008; 23(6): 423 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-l. Qiu, W. Wang, T. Wang, J. Liu, P. Sun, J. Qian, L. Jin, and Z.-l. Xia Genetic Polymorphisms, Messenger RNA Expression of p53, p21, and CCND1, and Possible Links with Chromosomal Aberrations in Chinese Vinyl Chloride-Exposed Workers Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2578 - 2584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. El-Zein, M. Fenech, M. S. Lopez, M. R. Spitz, and C. J. Etzel Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wojda, E. Zietkiewicz, and M. Witt Effects of age and gender on micronucleus and chromosome nondisjunction frequencies in centenarians and younger subjects Mutagenesis, May 1, 2007; 22(3): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. LAFFON, J. P. TEIXEIRA, S. SILVA, J. ROMA-TORRES, B. PEREZ-CADAHIA, J. MENDEZ, E. PASARO, and O. MAYAN Assessment of Occupational Genotoxic Risk in the Production of Rubber Tyres Ann. Hyg., August 1, 2006; 50(6): 583 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kirsch-Volders, R. A. Mateuca, M. Roelants, A. Tremp, E. Zeiger, S. Bonassi, N. Holland, W. P. Chang, P. V. Aka, M. DeBoeck, et al. The Effects of GSTM1 and GSTT1 Polymorphisms on Micronucleus Frequencies in Human Lymphocytes In vivo. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1038 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rosefort, E. Fauth, and H. Zankl Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay Mutagenesis, July 1, 2004; 19(4): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sinues, A. Fanlo, M. L. Bernal, M. Val, and E. Mayayo Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans Human and Experimental Toxicology, March 1, 2004; 23(3): 107 - 113. [Abstract] [PDF]
|
|
|
|
|
|
A. Dhawan, M. A. Kayani, J. M. Parry, E. Parry, and D. Anderson Aneugenic and clastogenic effects of doxorubicin in human lymphocytes Mutagenesis, November 1, 2003; 18(6): 487 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Norppa and G. C.-M. Falck What do human micronuclei contain? Mutagenesis, May 1, 2003; 18(3): 221 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pastor, A. Creus, T. Parron, A. Cebulska-Wasilewska, C. Siffel, S. Piperakis, and R. Marcos Biomonitoring of four European populations occupationally exposed to pesticides: use of micronuclei as biomarkers Mutagenesis, May 1, 2003; 18(3): 249 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Touil, P. V. Aka, J.-P. Buchet, H. Thierens, and M. Kirsch-Volders Assessment of genotoxic effects related to chronic low level exposure to ionizing radiation using biomarkers for DNA damage and repair Mutagenesis, May 1, 2002; 17(3): 223 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pastor, L. Lucero, S. Gutierrez, R. Durban, C. Gomez, T. Parron, A. Creus, and R. Marcos A follow-up study on micronucleus frequency in Spanish agricultural workers exposed to pesticides Mutagenesis, January 1, 2002; 17(1): 79 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pastor, S. Gutierrez, A. Creus, N. Xamena, S. Piperakis, and R. Marcos Cytogenetic analysis of Greek farmers using the micronucleus assay in peripheral lymphocytes and buccal cells Mutagenesis, November 1, 2001; 16(6): 539 - 545. [Abstract] [Full Text] [PDF]
|
|